BofA Securities Maintains BrightSpring Health Services(BTSG.US) With Buy Rating
BTIG Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $25
Leerink Partners Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $22
Mizuho Securities Maintains BrightSpring Health Services(BTSG.US) With Buy Rating
BrightSpring Health Services, Inc.: Strategic Divestiture Fuels Strong Buy Rating and Growth Outlook
Mizuho Securities Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $22
Morgan Stanley Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $20
CJS Securities Initiates BrightSpring Health Services(BTSG.US) With Buy Rating, Announces Target Price $27
BrightSpring Health Svcs Is Maintained at Buy by B of A Securities
BrightSpring Health Analyst Ratings
BofA Securities Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $21
Wells Fargo Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $21
Wells Fargo Gives a Buy Rating to BrightSpring Health Services, Inc. (BTSG)
Deutsche Bank Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $20
BrightSpring Health Svcs Is Maintained at Outperform by Mizuho
BrightSpring Health Analyst Ratings
Morgan Stanley Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $19
Deutsche Bank Adjusts BrightSpring Health Services Price Target to $20 From $13, Maintains Buy Rating
BrightSpring Health Services: Strong Third-Quarter Performance and Positive Outlook Justify Buy Rating
BofA Securities Adjusts Price Target on BrightSpring Health Services to $16.50 From $14, Maintains Buy Rating